Navigation Links
PharmAthene Reports First Quarter 2012 Financial Results
Date:5/8/2012

s payable$

1,410,516$

1,445,700Accrued expenses and other liabilities2,850,0723,169,642Current portion of long term debt195,412-Short term debt857,808-Total current liabilities5,313,8084,615,342Other long term liabilities555,983449,709Long term debt, less current portion2,234,712-Derivative instruments2,878,3141,886,652Total liabilities10,982,8176,951,703Stockholders' equity:Common stock, $0.0001 par value; 100,000,000 shares authorized;
48,314,510 and 48,236,172 shares issued and outstanding at March 31, 2012
and December 31, 2011, respectively4,8324,824Additional paid-in-capital209,111,489208,525,917Accumulated other comprehensive income1,023,8911,010,522Accumulated deficit(196,369,345)(193,689,457)Total stockholders'
equity13,770,86715,851,806Total liabilities and stockholders' equity$

24,753,684$

22,803,509 PHARMATHENE, INC. 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONSThree months ended March 31,20122011Revenue

$

6,149,052$

6,337,722Operating expenses:Research and development4,705,3575,820,374General and administrative2,948,4814,939,654Depreciation and amortization85,910117,629Total operating expenses7,739,74810,877,657Loss from operations(1,590,696)(4,539,935)Other income (expense):Interest income2,9883,154Interest expense(3,028)(15,435)Other income (expense)52,915(11,906)Change in fair value of derivative instruments(991,662)2,488,465Total other income (expense)(938,787)2,464,278Net loss before income taxes(2,529,483)(2,075,657) Income tax expense(150,405)- Net loss

$

(2,679,888)$

(2,075,657)Basic and diluted net loss per share

$

(0.06)$

(0.04)Weighted average shares used in calculation of
basic and diluted net loss per share48,269,89446,276,874 


'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
2. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
3. PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
4. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
5. PharmAthene Reports Third Quarter 2011 Financial and Operating Results
6. PharmAthene Progresses Second Generation rPA Anthrax Vaccine
7. PharmAthene Appoints Brian A. Markison to the Companys Board of Directors
8. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
9. Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program
10. PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index
11. PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
(Date:7/30/2015)... ... July 30, 2015 , ... As part of its 2015 growth plan and as ... technical service business units, Whitehouse Laboratories is pleased to announce that it has ... the Container Center of Excellence and will be strictly dedicated to basic USP 51, USP ...
(Date:7/29/2015)... 2015 US-Australian drug discovery company, Novogen Limited ... is committed to progressing its ground-breaking technology platforms to ... to ensure the Company delivers the best value for ... Ross , said the Company currently had an extensive ... discovery programs and academic partnerships and initiatives, and he ...
(Date:7/29/2015)... College Station, TX (PRWEB) , ... July 29, ... ... cleanroom POD® designer, manufacturer and supplier, announces the launch of their 2nd generation ... compared to the current miniPOD CT, but it also represents a new POD® ...
Breaking Biology Technology:SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3
... improved IT infrastructure and enterprise plan for Wisconsin ... efficiency, according to presenters at the second annual ... the Monona Terrace. , ,Discussion focused on how ... increase access to broadband networks, educational services, and ...
... University of Wisconsin-Madison announced on Friday that it will be ... research. R. Timothy Mulcahy, a professor of pharmacology and associate ... become vice president of research at the University of Minnesota ... Martin Cadwallader said in a statement. He has been a ...
... recently saw the sudden death of another star. In this ... also not his birthplace. Unfortunately, few were around to sing ... last few weeks of the sudden death of biotech scientist ... in September of this year. An Argentine by birth, Frydman ...
Cached Biology Technology:Wisconsin introduces new state IT plan 2Wisconsin introduces new state IT plan 3Wisconsin introduces new state IT plan 4UW-Madison associate dean, active in stem cells, leaves 2An Argentine biotechman in Wisconsin 2An Argentine biotechman in Wisconsin 3An Argentine biotechman in Wisconsin 4
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical ... use solutions, headquartered in Springville, Utah , ... California corporation with locations in Santa ... Rica ). This acquisition will incorporate MedConx,s ... ATL Technology,s existing facility in Costa Rica ...
(Date:6/24/2015)... 2015 The biologics safety testing market is ... the market include growth of the pharmaceutical and biological ... Over the years, the number of drug approvals in ... the FDA approved 225 drug applications and Health Canada ... Europe accounted for 3,822 of the pharmaceutical ...
(Date:6/24/2015)... MARTIGNY, Switzerland , June 24, 2015 /PRNewswire/ ... strategic partnership with emerging biometric password solution one ... http://photos.prnewswire.com/prnh/20150623/225014LOGO one face in, ... offers a ground-breaking and affordable multifactor-authentication biometric answer ... speaker recognition technology, provided in partnership with KeyLemon, ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... attack. Since 2006, more than a million have been killed. ... not been enough evidence to implicate the suspectuntil now. ... is the causal agent of White-nose Syndrome (WNS), the fungal ... by Justin Boyles, a post-doctoral research associate in ecology and ...
... WASHINGTON, D.C. OCT. 31, 2011 A highly ... born to obese and diabetic women have a higher ... metabolic health problems later in life, received the March ... in the field of maternal-fetal nutrition. , ...
... Now, it,s on to proteins, a much more daunting task. ... protein molecules in our bodies. Many of these hold keys ... by Northwestern University chemical biologist Neil Kelleher has developed a ... protein molecules quickly. Many have been skeptical that such an ...
Cached Biology News:UT scientist helps confirm link between fungus and bat epidemic 2March of Dimes honors researcher who linked maternal obesity to a baby's long-term health 2So many proteins, so much promise 2So many proteins, so much promise 3
... Services include subcloning of gene in ... cells, isolation and plaque purification of ... virus stock for one clone, protein ... insect cell culture. Expected yield and ...
... Synthesis Service provides you with ... knockdown any gene. We offer ... pairs with terminal dT nucleotides), ... lengths of your choice. Each ...
EDTA, tetrasodium salt, 1 kg. Ethylene diaminetetraacetic acid.Dihydrate. Assay: 99-101% (as is).Risks: 36, 37, 38 ; Safety Precautions: 22, 36, 37. Category: Nucleotides & Enzymes & Biochemicals, Ul...
EDG-1 Western blot control Source: Cell Lysate Application: Western Blotting Control...
Biology Products: